Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles.

Nature communications·2025
Same author

PLB2<sub>Tau</sub> mice are impaired in novel and temporal object recognition and show corresponding traits in brain MRI.

Brain research bulletin·2024
Same author

Rapid and specific detection of thiabendazole: enzymatic digestion-enabled fluorescent aptasensor.

Analytical and bioanalytical chemistry·2024
Same author

Aptamer-based nanotrains and nanoflowers as quinine delivery systems.

International journal of pharmaceutics: X·2023
Same author

Glyphosate-Exonuclease Interactions: Reduced Enzymatic Activity as a Route to Glyphosate Biosensing.

Macromolecular bioscience·2023
Same author

Withdrawal notice to "Aptamer-based nanotrains and nanoflowers as quinine delivery systems" [Int. J. Pharm. 632 (2023) 122552].

International journal of pharmaceutics·2023

Related Experiment Video

Updated: May 13, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Aptamers as imaging agents.

Sonia Da Rocha Gomes1, Laurent Azéma, Michèle Allard

  • 1Novaptech, 2 rue Robert Escarpit, 33607 Pessac, France.

Expert Opinion on Medical Diagnostics
|March 19, 2013
PubMed
Summary
This summary is machine-generated.

Aptamer-based probes offer high-affinity targeting for diagnostics and therapeutics. These oligonucleotide probes are valuable for tumor imaging due to their binding and clearance properties.

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Related Experiment Videos

Last Updated: May 13, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Nanotechnology

Background:

  • Aptamers are structured oligonucleotides with high affinity and specificity for diverse targets.
  • Recent advances in imaging have spurred the development of aptamer-based probes for diagnostics.
  • Aptamers are emerging as key targeting molecules in advanced imaging applications.

Purpose of the Study:

  • To review aptamer-based imaging probes for ex vivo and in vivo applications.
  • To discuss the advantages and challenges associated with aptamer probe development.
  • To highlight the potential of aptamers in diagnostic and therapeutic applications.

Main Methods:

  • Aptamers are selected using systematic evolution of ligands by exponential enrichment (SELEX).
  • Oligonucleotides can be modified to enhance nuclease resistance and in vivo bioavailability.
  • Conjugation with labels (colorimetric, fluorescent, radiolabeled) enables detection of cancer-related antigens.

Main Results:

  • The review covers various aptamer-based imaging probes for both ex vivo and in vivo use.
  • Advantages of aptamer probes, including specificity and affinity, are presented.
  • Challenges in aptamer probe development, such as stability and delivery, are discussed.

Conclusions:

  • Aptamers demonstrate a broad range of applications from diagnostics to therapeutics.
  • Their specific binding, tumor retention, and clearance characteristics make them effective tumor imaging probes.